News Focus
News Focus
icon url

jerrybrockman

11/06/19 4:59 PM

#9662 RE: Steve Miller #9661

Might explain their shotgun approach to the patent, all those various versions. If Biogen is using one after Cerebain no longer pursued it, boom, it’ll be a huge hit with penny traders.